Related Experiment Video
Updated: May 11, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
A Tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1
Liron Bar-Peled1, Lynne Chantranupong, Andrew D Cherniack
1Whitehead Institute for Biomedical Research and Massachusetts Institute of Technology, Department of Biology, Cambridge, MA 02142, USA.
Abstract:
The mTOR complex 1 (mTORC1) pathway promotes cell growth in response to many cues, including amino acids, which act through the Rag guanosine triphosphatases (GTPases) to promote mTORC1 translocation to the lysosomal surface, its site of activation. Although progress has been made in identifying positive regulators of the Rags, it is unknown if negative factors also exist. Here, we identify GATOR as a complex that interacts with the Rags and is composed of two subcomplexes we call GATOR1 and -2. Inhibition of GATOR1 subunits (DEPDC5, Nprl2, and Nprl3) makes mTORC1 signaling resistant to amino acid deprivation. In contrast, inhibition of GATOR2 subunits (Mios, WDR24, WDR59, Seh1L, and Sec13) suppresses mTORC1 signaling, and epistasis analysis shows that GATOR2 negatively regulates DEPDC5. GATOR1 has GTPase-activating protein (GAP) activity for RagA and RagB, and its components are mutated in human cancer. In cancer cells with inactivating mutations in GATOR1, mTORC1 is hyperactive and insensitive to amino acid starvation, and such cells are hypersensitive to rapamycin, an mTORC1 inhibitor. Thus, we identify a key negative regulator of the Rag GTPases and reveal that, like other mTORC1 regulators, Rag function can be deregulated in cancer.
Insights
Researchers discovered GATOR, a complex that negatively regulates the Rag GTPases, which are crucial for cell growth signaling. Mutations in GATOR1 are linked to cancer, making mTORC1 signaling hyperactive and cells sensitive to rapamycin.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- The mTOR complex 1 (mTORC1) pathway is vital for cell growth, responding to nutrients like amino acids.
- Amino acids signal through Rag GTPases, facilitating mTORC1 activation at the lysosome.
- The existence of negative regulators for Rag GTPases was previously unknown.
Purpose of the Study:
- To identify negative regulators of the Rag GTPases.
- To elucidate the function of the GATOR complex in mTORC1 signaling.
- To investigate the role of GATOR components in human cancer.
Main Methods:
- Protein complex isolation and characterization (GATOR1 and GATOR2).
- Genetic manipulation to inhibit GATOR subunits and assess mTORC1 signaling.
- GTPase-activating protein (GAP) assays for Rag GTPases.
- Analysis of GATOR1 mutations in human cancer cell lines.
Main Results:
- GATOR, comprising GATOR1 and GATOR2 subcomplexes, interacts with Rag GTPases.
- GATOR1 acts as a GTPase-activating protein (GAP) for RagA and RagB.
- Inhibition of GATOR1 confers resistance to amino acid deprivation, while GATOR2 inhibition suppresses mTORC1 signaling.
- GATOR1 components are mutated in human cancer, leading to hyperactive mTORC1 signaling and rapamycin sensitivity.
Conclusions:
- GATOR is identified as a key negative regulator of Rag GTPases.
- Dysregulation of Rag GTPase function, via GATOR mutations, contributes to cancer.
- This discovery provides new insights into mTORC1 pathway regulation and its role in oncogenesis.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
The Ras Gene
Ras is a superfamily...
Abnormal Proliferation
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
